Health Archive » September, 2008

Health - September, 2008

149 articles

• Biocare Wins Bid To Drop AsymmetRx Patent Suit
• P&G Hits Teva With New Actonel Suit
• AstraZeneca Sues Accord Over Seroquel
• 2 Classes Certified In Drug Pricing Suit
• Abbott Unit's Injunction Bid Denied In Stent Spat
• Judge Throws Out Philips Defibrillator Patent Suit
• Judge Certifies Class In ERISA Suit Against Schering
• FDA Strengthens Medtronic Catheter Recall Status
• Cephalon Finalizes $425M Deal Over Off-Label Claims
• Rule 502 Is Now In Effect: What Will It Really Change?
• Crowell & Moring Snatches Six Lawyers From Pillsbury
• Eli Lilly Sues Teva Again Over Gemzar ANDA
• No Inequitable Conduct In $41M Lens Suit: Judge
• Fruit Of The Earth Settles Coppertone Sunblock Suit
• Willfulness Claim Struck In Suit Over Xopenex
• Plaintiffs Move To Settle Antitrust Action V. Roche
• Jury Awards $52M To Siemens Unit In Scanner Case
• Judge Axes Some Sham Litigation Claims Over TriCor
• Judge Boots Bristol-Myers False Claims Suit
• Iovate Settles Supplement Patent Suit
• Ex-Exec Allegedly Faked Cancer To Avoid SEC
• Biotech Settles False Claims Charges
• CVS Workers Call For Review In FLSA Case
• Pfizer Chief Litigation Counsel Joins Morgan Lewis
• Class Allegations Stand In WellPoint FLSA Suit
• Shire's Adderall Patent Suit To Go On
• Warranty Claims Shaved From 1st Seroquel Trials
• Zyprexa MDL Judge Orders States To Produce Docs
• CryoCath, Boston Scientific Unit Settle Patent Spat
• EU's New Rules For Labeling, Advertising Foodstuffs
• Roche Amends Boniva Suits Against Teva
• Health Care Policy Survey 2008: Legislation, Concerns
• Tying Case Against Amgen Voluntarily Dismissed
• Smiths Medical Dragged To Court Over Catheter Part
• Teva's Judgment Bid Nixed In Pulmicort Case
• Judge Chides Defendants In Restoril Patent Suit
• Medtronic, Abbott Fight For Judgment In Stent Feud
• Bayer Sues Sandoz, Watson Over Another Yaz Patent
• Sepracor, UMass Sue Over Liquid Clarinex ANDA
• FDA Yanks Eyewash, Skin Cream Over Side Effects
• Bayer May Be Liable For Texas Superfund Site
• No Quick Win For Corepharma In Epilepsy Drug Fight
• Hernia Patch Defense Can't Hire Plaintiffs' Docs: Judge
• Hospitals Partially Win Catheter Co. Antitrust Class
• Roxane Settles Price Inflation Suit For $1.8M
• Amgen's Enbrel Does Not Infringe Ariad Patent: Judge
• Invitrogen Hit With Suit Over Semiconductor Patents
• Judge Pools Drugstore Antitrust Cases Against AmEx
• Are Your ID Theft 'Red Flags' In Compliance Yet?
• FDA's Hearing On Allergen Advisory Labeling
• Medical Device Ads Scrutinized By Senate Panel
• House Committee Widens Ranbaxy Probe
• Stem Cell Patent Invalid: Consumer Watchdogs
• Judge Denies Sanctions Against States, Lilly In MDL
• Judge Splits Difference In Pfizer Discovery Dispute
• A Stark Change: New Regs Will Require Restructuring
• J&J Unit Resolves Monistat Suit Against Perrigo
• Ranbaxy Banks On Giuliani Amid FDA Drug Ban
• Longs Shakes Head At Walgreens' $3B Buyout Bid
• REACH Could Reduce Chemical Cos.' Profits: Report
• FDA Bars Ranbaxy Drugs For Manufacturing Violations
• Supreme Court Hears High Stakes Liability Cases
• Spectralytics, Cordis Stent Case Cleared For Trial
• BMS Sues Abbott Over Baby Formula Container Patent
• GSK's Curbs On Parallel Trading May Be Illegal: Court
• CoolTouch Hits Back At VNUS Over Laser Patents
• W.L. Gore Wins Judgment In Aneurysm Patent Feud
• EC Approves Teva's Generic Version Of Neupogen
• GAO Slams EPA For Not Protecting Children's Health
• Mo. Cigarette Suit Stuck In Discovery
• Abbott Prevails Against Yeda In Protein Patent Tiff
• GSK Wants USPTO Appeals Board Ruling Overturned
• Roche, Cobalt Drop Claims Over One Boniva Patent
• Wyeth's Vitamin Ads Draw Scrutiny From House Panel
• Fresenius Reaches Accord With FTC Over Anemia Drug
• Judge Reinstates $595M Award In Cordis Patent Suit
• Carnegie Mellon: A Key Ruling For Biotech Patents
• Teva Seeks To Bar FDA Approval Of Risperdal ANDAs
• Texas Lawyer Challenges Law Limiting Silica Suits
• Ill. CON Laws Threaten Competition: DOJ, FTC
• Ferring Looks To Chop Down Direct Purchaser Suits
• Fen-Phen Plaintiff Denied Cut Of Settlement
• Dentists Need A Push To Reduce Mercury: Report
• For Emergency Payment Disputes, Mediation Is Cure
• Lilly, States Quarrel Over Zyprexa Discovery
• Retroactive Rescission: Calif. Takes A Step Backward
• Medtronic Recalls Fatally Flawed Defibrillators
• EPA Fines Pharma For Wastewater Violations
• San Francisco Tobacco Rule Biased, Walgreen Claims
• Surgeons Ask For Injunction Over O.R. Slots
• VNUS Sues Bankrupt Rival Over Vein Surgery Patents
• FDA Considers Reclassifying Hemostatic Devices
• Don't Let Disruptive Doctors Hurt Your Accreditation
• GSK Seeks Final Approval For $40M Paxil Settlement
• Mylan Loses Bid To Dismiss Arthritis Drug Suit
• Abbott To Pay $28M To Settle Texas Medicaid Suit
• 5th Circ. Upholds Dismissal Of Cyberonics Class Action
• Longs Drug Stores Strikes Deal In CVS Merger Suits
• UnitedHealth CEO Pays Out $30M In Options Case
• Displaying Patented Device Isn't 'Use': Fed. Circ.
• Judge Keeps Athletic Trainers' Antitrust Suit Alive
• Appeals Ruling Ends 14-Year DNA Patent Case
• Fungal Settlements Reached In Contact Lens MDL
• Merck Misled USPTO In Singulair Patent Case: Teva
• University Of Iowa Claims Amgen Infringed Patents
• Retractable Sues To Protect Syringe Patents
• 3rd Circ. Revives Vioxx Securities Suit
• Institut Pasteur Tries To Block New Novartis Theory
• Preparing A Witness For A Successful Deposition
• Judge Won't Push Back Fen-Phen Lawyers' Trial
• CardioFocus Seeks 2nd Settlement In Patent Spat
• 3rd-Party Payer Class Certified In Zyprexa MDL
• Judge Gives Preliminary Approval To Par Settlement
• Suit Claims Ford Hid Faulty Truck Engines
• Blue Cross Loses Bid To Toss Monopsony Claims
• Philips Sues Siemens Over Patent For CT Scan Table
• La. Seeks Sanctions Against Eli Lilly In Zyprexa MDL
• Barr Fires Back At Celgene In Thalomid Patent Case
• Employer Must Pay All Costs Of Blood Test: 3rd Circ.
• Natural Health Execs Settle $2M Fraud Suit With SEC
• Md. Appeals Court Affirms Lilly Car Crash Ruling
• Pregnancy Test Patent Nixed In 10-Year Fight
• Hearing Aid Maker Asserts Brand-New Patent
• Pfizer's Reconsideration Bid Nixed In Securities Suit
• Apotex Loses Appeal In Risperdal Patent Fight
• Judge Denies GSK Plea To Drop Paxil Suicide Case
• Lawyers Question FDA's Changes To Labeling Rules
• FDA Demands Stronger Warnings For TNF-Blockers
• Hi-Tech Sues FDA To Get Generic Cosopt Exclusivity
• Privacy Of Genetic Info And GINA In An Electronic Age
• Dental Implant Makers Settle For $2M
• The Evolving Declaratory Judgment Standard
• Healthfirst To Pay $35M Over Medicaid Fraud
• Amended ANDA Triggers Another Detrol Complaint
• Family Says Formula Caused Baby's Meningitis
• Teva Sues Sandoz, Novartis Over Copaxone ANDA
• Court Rejects Knee Implant Patent Claim Construction
• Analyst Predicts Black Box Warning For Byetta
• Teva Sues Glenmark In Latest Suit Over Generic Coreg
• Telik Settles Securities Class Action For $5M
• Suspicions Persist Over Vytorin's Cancer Risk
• Medtronic Can Add Claims, But Stent Trial Bumped
• States Face Calls For Sanctions In Zyprexa MDL
• GSK Sues Lupin Over ANDA For HIV Drug Combivir
• Signalife Slapped With Securities Class Action
• Breckenridge Sues KV In Vitamin Patent Dispute
• Pa. Funeral Directors Admit Body Part Theft
• Purdue Pharma Strikes Licensing Deal For OxyContin
• Hospital Operator Settles Pregnancy Bias Case